Genus Plc engages in the provision of genetic livestock services to produce meat and milk. The company is headquartered in Basingstoke, Hampshire and currently employs 3,170 full-time employees. The company went IPO on 2000-07-06. The firm is advancing animal breeding and genetic improvement by applying biotechnology and selling added value products to livestock farming and food producers. The company focuses on the dairy, beef and pork food production sectors, through two businesses: ABS (bovine genetics) and PIC (porcine genetics). Its segments include Genus PIC, Genus ABS and Genus Research and Development. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. Its porcine and bovine divisions operate under the brand names PIC and ABS. The company operates in 30 countries, across six continents, and reaches a further 50 markets through distribution partners.
Mr. Jorgen Kokke 2023 'den beri şirketle birlikte olan Genus plc 'in Chief Executive Officer 'ıdır.
GENUS UNSPON ADR EA REPR 1 ORD hissesinin fiyat performansı nasıl?
GENUS UNSPON ADR EA REPR 1 ORD 'in mevcut fiyatı $37.84 'dir, son işlem günde 0% azalmış etti.
Genus plc için ana iş temaları veya sektörler nelerdir?
Genus plc Biotechnology endüstrisine ait ve sektör Health Care 'dir
Genus plc 'in piyasa değerlemesi nedir?
Genus plc 'in mevcut piyasa değerlemesi $2.5B 'dir
Genus plc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 12 analist Genus plc için analist derecelendirmeleri gerçekleştirdi, bunlar 7 güçlü al, 7 al, 2 tut, 0 sat ve 7 güçlü sat içermektedir